New Iza-bren Approvals Underscore China's Rising Role In Bispecific ADCs

기사 요약

Iza-bren was approved for recurrent or metastatic esophageal squamous cell carcinoma, after receiving earlier approval to treat nasopharyngeal carcinoma image credit: Bamboo Works Key Takeaways: New